DESVENLAFAXINE
These highlights do not include all the information needed to use DESVENLAFAXINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DESVENLAFAXINE EXTENDED-RELEASE TABLETS. DESVENLAFAXINE Extended-Release Tablets, for oral use Initial U.S. Approval: 2008
3fcc0555-f9cf-4735-a0ef-830c50c390b8
HUMAN PRESCRIPTION DRUG LABEL
May 7, 2025
NorthStar Rx LLC
DUNS: 830546433
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
DESVENLAFAXINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
DESVENLAFAXINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
DESVENLAFAXINE
Product Details
FDA regulatory identification and product classification information